Main >> Bayanin Magunguna, Labarai >> FDA ta amince da sauyawar Rx-to-OTC don maganin ƙoshin kai

FDA ta amince da sauyawar Rx-to-OTC don maganin ƙoshin kai

FDA ta amince da sauyawar Rx-to-OTC don maganin ƙoshin kaiLabarai

A cikin shekarun da ba a yaduwar cutar ba, kowane mahaifa yana fargabar samun wani kiran waya ko sanarwa daga makarantar sakandaren yayansu ko makarantar firamare: childanka yana da ƙoshin kai kuma ba zai iya komawa makaranta ba har sai an kawar da shi. Yanzu iyaye suna da zaɓi mafi sauƙi don kula da 'ya'yansu da kuma kawar da damuwa kwarkwatar kai , don haka yaransu zasu iya komawa aji, da sannu.





Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da maganin shafawa a baya-kawai don amfani da kan-kan-kan (OTC) don magance kwarkwata. Bayani (ivermectin) ana shafa shi a fatar kai da gashi don kashe kwarkwata na mintina 10 kafin a tsabtace shi sosai da ruwa.



Makonni shida zuwa 12 na cutar kwarkwata suna faruwa kowace shekara a cikin yara tsakanin shekaru 3 zuwa 11 a Amurka, a cewar Cibiyoyin Kula da Rigakafin Cututtuka (CDC).

Wannan labarin zai zama mai sanyaya zuciya ga duk waɗancan iyayen masu takaici suna neman ingantacciyar hanyar kawar da waɗannan ƙananan ƙwayoyin kwari da ƙwayayensu ƙanana, waɗanda aka sani da nits.

Yadda aka canza canjin

Abinda aka samo asali na 0.5% ivermectin shine asalin FDA ta amince dashi a 2012 don amfani dashi a cikin mutane masu shekaru 6 zuwa sama. Kamfanin Arbor Pharmaceuticals ne, LLC ke ƙera shi. Kafin wannan shawarar, ana samun Sklice ne kawai tare da takardar sayan magani.



FDA tayi amfani da tsarin canza Rx-to-OTC don yin wannan ruwan shafawa mai amfani sau ɗaya a shagon magani ga marasa lafiya ba tare da ziyarar likitan yara ba da farko.

Amincewar ta faɗaɗa damar yin amfani da wani magani mai mahimmanci ga dubunnan mutanen da ke fama da ƙoshin kai, in ji shi Theresa Michele, MD , mukaddashin darekta na Ofishin Magunguna marasa magani a Cibiyar Kula da Nazarin Magunguna da Bincike ta FDA a cikin wata sanarwa.

Tsarin Rx-to-OTC an tsara shi ne don haɓaka damar samun mabukaci ga magunguna waɗanda yawanci ana samun su ta hanyar takardar sayan magani. A cewar FDA, waɗannan sauyawar galibi masana'antun magunguna ne ke farawa da su. Dole ne su nuna cewa za a iya amfani da miyagun ƙwayoyi lafiya idan an miƙa su ba tare da takardar sayan magani ba.



(Wani nau'in ivermectin a cikin tsari na kashi 1.0% na ci gaba da buƙatar takardar sayan magani. Wannan sigar, wacce ake amfani da ita a maganin rosacea, ana sayar da ita a ƙarƙashin sunan alama Soolantra , daga dakunan gwaje-gwaje na Galderma.)

Sauran maganin kwarkwata

Baya ga Sklice, iyaye na iya gwada waɗannan zaɓuɓɓukan magani .

Zasu iya zaɓar samfurin shamfu na OTC wanda ya ƙunshi permethrin , maganin kashe kwari wanda yake da illa ga kwarkwata, ko kuma wani fili wanda aka sani da suna pyrethrin. Zaɓuɓɓukan sun haɗa da:



  • Babu komai : Nix kayayyakin, wanda ya ƙunshi permethrin, ana samun su azaman shamfu da kirim mai tsami don gashi, da samfurin haɗuwa, Nix Ultra Super Lice Jiyya .
  • Kawar da : Kuna iya tafiya tare A kawar da Shamfu mai kashe Lice , ko zaɓi Kayan Cire Cire Maɗaukaki MAX ko Cire MAX Cikakken Kit . Abubuwan da ke aiki a cikin Rid sune piperonyl butoxide da pyrethrins.

Ko kuma za su fi son zuwa tare da takardar magani-ƙarfin magani. Mai ba da lafiyar ku zai iya zaɓar tsakanin ruwan shafawa na pediculicide ko shamfu mai kashe yara, duka an yi niyyar kashe kwarkwata. Kayan shafawa wadanda suka hada da:

  • Natroba : Natroba (spinosad) magani ne na yau da kullun don ƙoshin kai wanda ya kasance FDA ta amince da shi a cikin 2011 . Yawanci yakan zo a cikin kwalba na 120 mL na ƙarfin ƙarfin kashi 0.9 bisa ɗari. Za ki shafa shi a busasshen gashi da fatar kan mutum, sai a bar shi ya zauna na minti goma, sannan a tsabtace shi da ruwan dumi.
  • Ovid : Ovid ( zazzaɓi ) wani maganin shafawa ne wanda yake sawa kwarkwatar kai da qwai, shima.
  • Lindane : Shampoo ta Lindane magani ce da aka shirya don magance ƙishi.

Kafin amfani da duk wani magani na maganin kwarkwata, bincika likitan ka ko likitan ka, domin wasu magungunan na iya samun takunkumin shekaru, ko kuma kana bukatar daukar wasu matakan kariya yayin amfani dasu ko amfani dasu.